Zobrazeno 1 - 10
of 82
pro vyhledávání: '"R A Krom"'
Autor:
Y, Maor-Kendler, K P, Batts, L J, Burgart, R H, Wiesner, R A, Krom, C B, Rosen, M R, Charlton
Publikováno v:
Transplantation. 70(2)
End-stage liver disease for which no cause can be identified, cryptogenic cirrhosis, is a common indication for liver transplantation. Allograft inflammation and fibrosis have been reported to recur with similar frequencies after liver transplantatio
Publikováno v:
Transplantation. 66(3)
Poor graft function early after liver transplantation is an important cause of morbidity and mortality. We defined early allograft dysfunction (EAD) using readily available indices of function and identified donor, graft, and pretransplant recipient
Autor:
M R, Charlton, D, Brandhagen, R H, Wiesner, J B, Gross, J, Detmer, M, Collins, J, Kolberg, R A, Krom, D H, Persing
Publikováno v:
Transplantation. 65(1)
The significance of hepatitis G (HGV) infection in liver transplant recipients is not known. We set out to determine the pre-orthotopic liver transplantation (OLT) prevalence, the pre- and postoperative viral titers of HGV, and the allograft histolog
Autor:
I W, Graziadei, R H, Wiesner, P J, Marotta, M K, Porayko, L J, Dahlke, S M, Wilson, J L, Steers, R A, Krom
Publikováno v:
Transplantation. 64(5)
In a randomized, controlled study we investigated the clinical efficacy of the microemulsion formulation of cyclosporine (Neoral) in comparison with Sandimmune (SIM) in the treatment of patients who underwent primary orthotopic liver transplantation
Publikováno v:
Transplantation. 63(4)
Our aim was to determine whether calpain protease activity is increased in liver tissue from allografts that have poor graft function postoperatively. Liver tissue was obtained from 36 patients at 1 hr after recirculation. The patients were divided i
Autor:
R H, Wiesner, R A, Krom
Publikováno v:
Clinical transplants.
During the past 12 years, the Mayo Clinic Liver Transplant Program has continued to flourish. Not only has the program steadily grown in the numbers of patients transplanted, but now we are achieving an overall 90% one-year survival rate and have red
Publikováno v:
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 3(1)
Jejunoileal bypass (JIB) is a well known cause of steatohepatitis, which may, on occasion, progress to cirrhosis and require liver transplantation. We report 3 patients who underwent orthotopic liver transplantation (OLT) for steatohepatitic cirrhosi
Publikováno v:
Transplantation. 62(11)
Transplant immunosuppression using either cyclosporine (CsA) or tacrolimus (FK506) leads to renal vasoconstriction and nephrotoxicity. Despite producing similar effects within the kidney and blood vessels, clinical hypertension occurs less frequently
Autor:
R, Patel, D, Portela, A D, Badley, W S, Harmsen, J J, Larson-Keller, D M, Ilstrup, M R, Keating, R H, Wiesner, R A, Krom, C V, Paya
Publikováno v:
Transplantation. 62(7)
Fungal infections are associated with a high mortality rate after liver transplantation. To describe risk factors for fungal infections, 405 consecutive liver transplant recipients were analyzed. Forty-five patients (11%) developed invasive fungal in
Publikováno v:
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2(5 Suppl 1)
The results of liver transplantation in patients with PSC are excellent and the quality of life is markedly improved. Indeed, liver transplantation is the therapy of choice for patients with end-stage PSC. However, in an age of cost containment, it a